Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

Disease induced

Disease-induced compounds are chemical agents used to simulate specific pathological conditions in experimental systems, such as cell cultures, organoids, or animal models.

Disease-induced compounds play a pivotal role in translational biomedical research, allowing researchers to reproduce key features of human diseases under controlled conditions, enabling the study of disease mechanisms and the testing of therapeutic interventions. For example, neurotoxins such as MPTP are widely used to model Parkinson’s disease by selectively damaging dopaminergic neurons, while streptozotocin and alloxan are used to induce diabetes through pancreatic β-cell destruction. Similarly, agents like carbon tetrachloride, bleomycin, and lipopolysaccharide are utilized to reproduce hepatic injury, pulmonary fibrosis, and systemic inflammation, respectively.

Through the application of disease-induced compounds, researchers can bridge the gap between basic molecular research and translational medicine. Their use facilitates the elucidation of disease mechanisms and supports the rational design and preclinical testing of novel therapeutic agents.

Items 1-10 of 133

Page
per page
  1. Bleomycin Sulfate
    A8331 Bleomycin Sulfate
     13 Citation
    Summary: A chemotherapeutic agent that induces DNA strand breaks, commonly used to construct pulmonary fibrosis animal models.
      ≥125 mg/mL
  2. Dextran sulfate sodium salt (MW 35000-45000)
    B8205 Dextran sulfate sodium salt (MW 35000-45000)
     7 Citation
    Summary: A nucleic acid hybridization promoter, commonly used to construct acute and chronic colitis models.
      insoluble in EtOH; insoluble in DMSO; ≥55.5 mg/mL
  3. Vancomycin
    C6417 Vancomycin
     3 Citation
    Summary: An antibiotic that treats bacterial infections by inhibiting bacterial cell wall synthesis; high-dose administration induces acute kidney injury (nephrotoxicity) models in rats/mice.
      insoluble in H2O; insoluble in EtOH; ≥97.2 mg/mL
  4. Okadaic acid
    A4540 Okadaic acid
    Summary: A protein phosphatase 1 inhibitor, commonly used to construct Alzheimer's disease (tau hyperphosphorylation) animal models.
      Soluble in DMSO
  5. Angiotensin II
    A1042 Angiotensin II
     35 Citation
    Summary: A potent vasopressor that selectively activates angiotensin II type 1 receptors (AT1R), commonly used to construct hypertension animal models.
      ≥12.58 mg/mL
  6. Tamoxifen
    B5965 Tamoxifen
     28 Citation
    Target: PKC
    Summary: An orally active selective estrogen receptor modulator (SERM) that can also induce gene knockout in CreER transgenic mice.
      ≥18.6 mg/mL
  7. Doxorubicin
    A3966 Doxorubicin
     40 Citation
    Summary: DNA topoisomerase II inhibitor
      ≥27.2 mg/mL
  8. Doxorubicin (Adriamycin) HCl
    A1832 Doxorubicin (Adriamycin) HCl
     15 Citation
    Target: Topoisomerases
    Summary: A cytotoxic anthracycline antibiotic used in anticancer chemotherapy, commonly used to construct cardiomyopathy (anthracycline cardiotoxicity) animal models.
      ≥29 mg/mL
  9. 12-O-tetradecanoyl phorbol-13-acetate (PMA)
    N2060 12-O-tetradecanoyl phorbol-13-acetate (PMA)
     23 Citation
    Summary: An ERK/MAPK activator, commonly used to construct mouse skin tumor promotion (two-stage carcinogenesis) and acute inflammation animal models.
      insoluble in H2O; ≥112.9 mg/mL
  10. Prostaglandin E2
    B7005 Prostaglandin E2
     3 Citation
    Target: Prostaglandin EP receptors
    Summary: An endogenous prostaglandin, commonly used to construct PGE2-induced hyperalgesia/allodynia (intrathecal injection) and inflammation-related bone loss animal models.
      ≥35.2 mg/mL

Items 1-10 of 133

Page
per page